|
1
|
Anavi S and Tirosh O: iNOS as a metabolic
enzyme under stress conditions. Free Radic Biol Med. 146:16–35.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Goldstein S and Merényi G: The chemistry
of peroxynitrite: Implications for biological activity. Methods
Enzymol. 436:49–61. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang B, Wang Y, Wang Y, Zhao Y, Yang C,
Zeng Z, Huan S, Song G and Zhang X: Oxygen-embedded pentacene based
near-infrared chemiluminescent nanoprobe for highly selective and
sensitive visualization of peroxynitrite in vivo. Anal Chem.
92:4154–4163. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Eiserich JP, Estévez AG, Bamberg TV, Ye
YZ, Chumley PH, Beckman JS and Freeman BA: Microtubule dysfunction
by posttranslational nitrotyrosination of alpha-tubulin: A nitric
oxide-dependent mechanism of cellular injury. Proc Natl Acad Sci
USA. 96:6365–6370. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bartesaghi S and Radi R: Fundamentals on
the biochemistry of peroxynitrite and protein tyrosine nitration.
Redox Biol. 14:618–625. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tampa M, Mitran MI, Mitran CI, Sarbu MI,
Matei C, Nicolae I, Caruntu A, Tocut SM, Popa MI, Caruntu C and
Georgescu SR: Mediators of inflammation-A potential source of
biomarkers in oral squamous cell carcinoma. J Immunol Res.
2018:10617802018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lee BJ, Chan MY, Hsiao HY, Chang CH, Hsu
LP and Lin PT: Relationship of Oxidative Stress, Inflammation, and
the Risk of Metabolic Syndrome in Patients with Oral Cancer. Oxid
Med Cell Longev. 2018:93030942018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chaiyarit P, Ma N, Hiraku Y, Pinlaor S,
Yongvanit P, Jintakanon D, Murata M, Oikawa S and Kawanishi S:
Nitrative and oxidative DNA damage in oral lichen planus in
relation to human oral carcinogenesis. Cancer Sci. 96:553–559.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Silva Servato JP, Ueira Vieira C, de Faria
PR, Cardoso SV and Loyola AM: The importance of inducible nitric
oxide synthase and nitrotyrosine as prognostic markers for oral
squamous cell carcinoma. J Oral Pathol Med. 48:967–975. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Olek M, Kasperski J, Skaba D, Wiench R,
Cieślar G and Kawczyk-Krupka A: Photodynamic therapy for the
treatment of oral squamous carcinoma-clinical implications
resulting from in vitro research. Photodiagnosis Photodyn Ther.
27:255–267. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Irani S: Pre-cancerous lesions in the oral
and maxillofacial region: A literature reviewwith special focus on
etiopathogenesis. Iran J Pathol. 11:303–322. 2016.PubMed/NCBI
|
|
12
|
Vucicevic Boras V, Fucic A, Virag M,
Gabric D, Blivajs I, Tomasovic-Loncaric C, Rakusic Z, Bisof V,
Novere NL and Velimir Vrdoljak D: Significance of stroma in biology
of oral squamous cell carcinoma. Tumori. 104:9–14. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bao X, Liu F, Lin J, Chen Q, Chen L, Chen
F, Wang J, Qiu Y, Shi B, Pan L, et al: Nutritional assessment and
prognosis of oral cancer patients: A large-scale prospective study.
BMC Cancer. 20:1462020. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang SS, Zheng M, Pang X, Zhang M, Yu XH,
Wu JB, Gao XL, Wu JS, Yang X, Tang YJ, et al: Macrophage migration
inhibitory factor promotes the invasion and metastasis of oral
squamous cell carcinoma through matrix metalloprotein-2/9. Mol
Carcinog. 58:1809–1821. 2019. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ortiz RC, Lopes NM, Amôr NG, Ponce JB,
Schmerling CK, Lara VS, Moyses RA and Rodini CO: CD44 and ALDH1
immunoexpression as prognostic indicators of invasion and
metastasis in oral squamous cell carcinoma. J Oral Pathol Med.
47:740–747. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Romer CAE, Broglie Daeppen MA, Mueller M,
Huber GF, Guesewell S and Stoeckli SJ: Long-term speech and
swallowing function after primary resection and sentinel node
biopsy for early oral squamous cell carcinoma. Oral Oncol.
89:127–132. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Deng W, Yang L, Xie C, Lu H, Xiao Y, Zeng
B, Liang Y and Liao G: Prediction of postoperative lower
respiratory tract infections in tongue cancer patients based on
pretreatment swallowing function. Oral Dis. 26:537–546. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Goswami S and Gupta SS: How cancer of oral
cavity affects the family caregivers? -A cross-sectional study in
Wardha, India, using the caregiver quality of life index-cancer
questionnaire. South Asian J Cancer. 9:62–65. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sun Y, Liu N, Guan X, Wu H, Sun Z and Zeng
H: Immunosuppression induced by chronic inflammation and the
progression to oral squamous cell carcinoma. Mediators Inflamm.
2016:57157192016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xu L, Hou TJ and Yang P: Mechanism of
lncRNA FEZF1-AS1 in promoting the occurrence and development of
oral squamous cell carcinoma through targeting miR-196a. Eur Rev
Med Pharmacol Sci. 23:6505–6515. 2019.PubMed/NCBI
|
|
21
|
Xiao T, Sun J, Xing Z, Xie F, Yang L and
Ding W: MTFP1 overexpression promotes the growth of oral squamous
cell carcinoma by inducing ROS production. Cell Biol Int.
44:821–829. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sanada H, Seki N, Mizuno K, Misono S,
Uchida A, Yamada Y, Moriya S, Kikkawa N, Machida K, Kumamoto T, et
al: Involvement of dual strands of miR-143 (miR-143-5p and
miR-143-3p) and their target oncogenes in the molecular
pathogenesis of lung adenocarcinoma. Int J Mol Sci. 20:44822019.
View Article : Google Scholar
|
|
23
|
Liu J, Li H, Shen S, Sun L, Yuan Y and
Xing C: Alternative splicing events implicated in carcinogenesis
and prognosis of colorectal cancer. J Cancer. 9:1754–1764. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wen R, Xiao Y, Zhang Y, Yang M, Lin Y and
Tang J: Identification of a novel transcript isoform of the TTLL12
gene in human cancers. Oncol Rep. 36:3172–3180. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Massoner P, Lueking A, Goehler H, Höpfner
A, Kowald A, Kugler KG, Amersdorfer P, Horninger W, Bartsch G,
Schulz-Knappe P and Klocker H: Serum-autoantibodies for discovery
of prostate cancer specific biomarkers. Prostate. 72:427–436. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Li H, Huang Y, Yu Y, Li G and Karamanos Y:
Self-catalyzed assembly of peptide scaffolded nanozyme as a dynamic
biosensing system. ACS Appl Mater Interfaces. 8:2833–2839. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wasylyk C, Zambrano A, Zhao C, Brants J,
Abecassis J, Schalken JA, Rogatsch H, Schaefer G, Pycha A, Klocker
H and Wasylyk B: Tubulin tyrosine ligase like 12 links to prostate
cancer through tubulin posttranslational modification and
chromosome ploidy. Int J Cancer. 127:2542–2553. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Robert BM, Dakshinamoorthy M,
Ganapathyagraharam Ramamoorthy B, Dhandapani M, Thangaiyan R,
Muthusamy G, Nirmal RM and Prasad NR: Predicting tumor sensitivity
to chemotherapeutic drugs in oral squamous cell carcinoma patients.
Sci Rep. 8:155452018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wood SC, Tang X and Tesfamariam B:
Paclitaxel potentiates inflammatory cytokine-induced prothrombotic
molecules in endothelial cells. J Cardiovasc Pharmacol. 55:276–285.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhou X, Wu J, Hao Y, Zhu C, Zhuo Q, Xia H
and Zhu J: Rational design and synthesis of unsaturated
se-containing osmacycles with σ-aromaticity. Chemistry.
24:2389–2395. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ensafi AA, Dadkhah-Tehrani S and
Karimi-Maleh H: Voltammetric determination of glutathione in
haemolysed erythrocyte and tablet samples using modified-multiwall
carbon nanotubes paste electrode. Drug Test Anal. 4:978–985. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Miyawaki A, Hijioka H, Ikeda R, Ishida T,
Nozoe E and Nakamura N: Analysis of the outcome of concurrent
neoadjuvant chemoradiotherapy with S-1 compared to super-selective
intra-arterial infusion for oral squamous cell carcinoma. Oncol
Lett. 3:995–1001. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Feng X, Luo Q, Zhang H, Wang H, Chen W,
Meng G and Chen F: The role of NLRP3 inflammasome in 5-fluorouracil
resistance of oral squamous cell carcinoma. J Exp Clin Cancer Res.
36:812017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kim J and Chan JJ: Cyclophosphamide in
dermatology. Australas J Dermatol. 58:5–17. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Olasz L, Orsi E, Markó T and Szalma J:
Induction chemotherapy response and recurrence rates in correlation
with N0 or N+ stage in oral squamous cell cancer (OSCC). Cancer
Metastasis Rev. 29:607–611. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Blanchard-Fillion B, Prou D, Polydoro M,
Spielberg D, Tsika E, Wang Z, Hazen SL, Koval M, Przedborski S and
Ischiropoulos H: Metabolism of 3-nitrotyrosine induces apoptotic
death in dopaminergic cells. J Neurosci. 26:6124–6130. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Goodson HV and Jonasson EM: Microtubules
and Microtubule-Associated Proteins. Cold Spring Harb Perspect
Biol. 10:a0226082018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Akhmanova A and Steinmetz MO: Control of
microtubule organization and dynamics: Two ends in the limelight.
Nat Rev Mol Cell Biol. 16:711–726. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Magiera MM, Singh P, Gadadhar S and Janke
C: Tubulin posttranslational modifications and emerging links to
human disease. Cell. 173:1323–1327. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Janke C and Montagnac G: Causes and
consequences of microtubule acetylation. Curr Biol. 27:R1287–R1292.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Nieuwenhuis J and Brummelkamp TR: The
tubulin detyrosination cycle: Function and enzymes. Trends Cell
Biol. 29:80–92. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kalisz HM, Erck C, Plessmann U and Wehland
J: Incorporation of nitrotyrosine into alpha-tubulin by recombinant
mammalian tubulin-tyrosine ligase. Biochim Biophys Acta.
1481:131–138. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Song W, Cho Y, Watt D and Cavalli V:
Tubulin-tyrosine ligase (TTL)-mediated increase in tyrosinated
α-tubulin in injured axons is required for retrograde injury
signaling and axon regeneration. J Biol Chem. 290:14765–14775.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Rivelli JF, Ochoa AL, Santander VS, Nigra
A, Previtali G and Casale CH: Regulation of aldose reductase
activity by tubulin and phenolic acid derivates. Arch Biochem
Biophys. 654:19–26. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Bajaj S, Roy PP and Singh J:
1,3,4-oxadiazoles as telomerase inhibitor: Potential anticancer
agents. Anticancer Agents Med Chem. 17:1869–1883. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Zugazagoitia J, Guedes C, Ponce S, Ferrer
I, Molina-Pinelo S and Paz-Ares L: Current challenges in cancer
treatment. Clin Ther. 38:1551–1566. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
De Marchi P, Melendez ME, Laus AC,
Kuhlmann PA, de Carvalho AC, Arantes LMRB, Evangelista AF, Andrade
ES, de Castro G Junior, Reis RM, et al: The role of
single-nucleotide polymorphism (SNPs) in toxicity of induction
chemotherapy based on cisplatin and paclitaxel in patients with
advanced head and neck cancer. Oral Oncol. 98:48–52. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Fugazzola L, Muzza M, Pogliaghi G and
Vitale M: Intratumoral genetic heterogeneity in papillary thyroid
cancer: Occurrence and clinical significance. Cancers (Basel).
12:3832020. View Article : Google Scholar
|
|
49
|
Mimoto R, Yogosawa S, Saijo H, Fushimi A,
Nogi H, Asakura T, Yoshida K and Takeyama H: Clinical implications
of drug-screening assay for recurrent metastatic hormone
receptor-positive, human epidermal receptor 2-negative breast
cancer using conditionally reprogrammed cells. Sci Rep.
9:134052019. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Hoffman RM and Tanino H: Clinical
usefulness of the histoculture drug response assay for breast
cancer. Methods Mol Biol. 1760:93–100. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Franck S, Fuhrmann-Selter T, Joseph JF,
Michelet R, Casilag F, Sirard JC, Wicha SG and Kloft C: A rapid,
simple and sensitive liquid chromatography tandem mass spectrometry
assay to determine amoxicillin concentrations in biological matrix
of little volume. Talanta. 201:253–258. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Wu CP, Lusvarghi S, Tseng PJ, Hsiao SH,
Huang YH, Hung TH and Ambudkar SV: MY-5445, a phosphodiesterase
type 5 inhibitor, resensitizes ABCG2-overexpressing
multidrug-resistant cancer cells to cytotoxic anticancer drugs. Am
J Cancer Res. 10:164–178. 2020.PubMed/NCBI
|
|
53
|
Dhiman N, Kingshott P, Sumer H, Sharma CS
and Rath SN: On-chip anticancer drug screening-recent progress in
microfluidic platforms to address challenges in chemotherapy.
Biosens Bioelectron. 137:236–254. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Mourelatos D: Sister chromatid exchange
assay as a predictor of tumor chemoresponse. Mutat Res Genet
Toxicol Environ Mutagen. 803:1–12. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Zhang L, Li B, Zhang B, Zhang H and Suo J:
miR-361 enhances sensitivity to 5-fluorouracil by targeting the
FOXM1-ABCC5/10 signaling pathway in colorectal cancer. Oncol Lett.
18:4064–4073. 2019.PubMed/NCBI
|
|
56
|
Sticozzi C, Aiello F, Andreasi RB, Muresan
XM, Belmonte G, Cervellati F, Maellaro E, Maioli E and Valacchi G:
Antitubulinic effect of new fluorazone derivatives on melanoma
cells. Anticancer Agents Med Chem. 16:601–608. 2016. View Article : Google Scholar : PubMed/NCBI
|
